Drug Shortage Report for HYZAAR
| Report ID | 71160 |
| Drug Identification Number | 02230047 |
| Brand name | HYZAAR 50/12.5MG |
| Common or Proper name | losartan potassium and hydrochlorothiazide tablets |
| Company Name | ORGANON CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM |
| Strength(s) | 12.5MG 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | Pack of 30 tablets |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | 2019-01-23 |
| Actual start date | 2019-01-23 |
| Estimated end date | 2019-04-19 |
| Actual end date | 2019-04-15 |
| Shortage status | Resolved |
| Updated date | 2019-04-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16766 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-844-820-5468 [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2019-01-03 | English | Compare |